Connection

YI ZHU to Mice, Transgenic

This is a "connection" page, showing publications YI ZHU has written about Mice, Transgenic.
Connection Strength

0.296
  1. The potential of 4-Methylumbelliferone to be repurposed for treating liver fibrosis. Biomed Pharmacother. 2025 Sep; 190:118427.
    View in: PubMed
    Score: 0.155
  2. FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression. Cell Metab. 2025 Jul 01; 37(7):1547-1567.e6.
    View in: PubMed
    Score: 0.038
  3. Distinct systemic impacts of A?42 and Tau revealed by whole-organism snRNA-seq. Neuron. 2025 Jul 09; 113(13):2065-2082.e8.
    View in: PubMed
    Score: 0.038
  4. Null mutation of peroxisome proliferator-activated receptor-interacting protein in mammary glands causes defective mammopoiesis. J Biol Chem. 2004 Aug 06; 279(32):33696-701.
    View in: PubMed
    Score: 0.036
  5. Adiponectin preserves metabolic fitness during aging. Elife. 2021 04 27; 10.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.